Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Russian Bear who wrote (431)	1/19/1999 1:00:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1073

RB: I follow them closely. I sleep, breathe and eat them. They drive me nuts. Great results as presented. However, the proposed mechanism of action is just so convoluted and far-fetched that I just can't buy. They propose that tumors attract phagocytes and NK cells. They also propose that the NK cells would kill tumor cells, but that they themselves are inactivated by oxidative damage from the phagocytes. They claim that their Maxamine (sp?) neutralizes the phagocytes. It is not clear to me how the NK cells would focus at a tumor in the first place. Going beyond that is just too much for me to stomach. The company is very good at PR. Lotsa money to be made, but I'm not certain that the picture will always look bright. That is, I'm confused. Rick